
ASX 200 Health Sector Lags but Amplia and Biotech Peers Shine in June
Highlights ASX 200 Health Care sector underperforms broader index despite isolated stock rallies Amplia Therapeutics records complete cancer responses in ACCENT trial Neuro and radiopharma companies advance on clinical updates and acquisitions The ASX 200 …